Filing Details

Accession Number:
0001179110-15-012683
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-26 19:54:07
Reporting Period:
2015-08-24
Filing Date:
2015-08-26
Accepted Time:
2015-08-26 19:54:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1323113 Jr N Daniel Swisher C/o Sunesis Pharmaceuticals, Inc.
395 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-24 12,784 $1.01 187,520 No 4 P Indirect See footnote.
Common Stock Acquisiton 2015-08-25 12,216 $1.01 199,736 No 4 P Indirect See footnote.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote.
No 4 P Indirect See footnote.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 179,510 Direct
Footnotes
  1. Because of a typographical error, the amount of securities beneficially owned indirectly by the reporting person was incorrectly reported as 174,336 shares instead of 174,736 shares in the last Form 4 filing. The total amount of the reporting person's indirect holdings on this report incorporates this correction.
  2. The shares are held by the Swisher Revocable Trust for which reporting person is a Trustee.